Ramin Farzaneh-Far
Technik-/Wissenschafts-/F&E-Leiter bei RA PHARMACEUTICALS, INC.
Ursprung des Netzwerks ersten Grades von Ramin Farzaneh-Far
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 42 | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.
27
| Operating Division | Investment Managers | 27 |
| Subsidiary | Pharmaceuticals: Major | 25 | |
Pepgen Ltd.
 Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom.
3
| Subsidiary | Packaged Software | 3 |
| Public Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ramin Farzaneh-Far
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Chief Executive Officer Portfolio Manager-Equities Portfolio Manager-Equities Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor | |
| PEPGEN INC. | Biotechnology | Chief Executive Officer Director/Board Member Founder Founder | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Investor Relations Contact Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INOZYME PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| RESEARCH ALLIANCE CORP. II | Financial Conglomerates | Chief Executive Officer Founder Director of Finance/CFO | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
Superluminal Medicines Inc
 Superluminal Medicines Inc BiotechnologyHealth Technology Superluminal Medicines Inc is a generative biological and chemical company. The company is based in Boston, MA. The CEO of the company is Cony D'Cruz. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| ABBVIE INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal General Counsel | |
| University of California, Los Angeles | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Director/Board Member | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree General Counsel | |
Aliada Therapeutics, Inc.
 Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | Miscellaneous Commercial Services | Chairman Founder Director/Board Member | |
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Santi Therapeutics, Inc. provides pharmaceutical services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Bentley University | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Doctorate Degree | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 49 |
| Belgien | 2 |
| Singapur | 2 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 10 |
| Finance | 6 |
| Health Services | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 371 |
| Corporate Officer/Principal | 181 |
| Independent Dir/Board Member | 113 |
| Undergraduate Degree | 79 |
| Chief Tech/Sci/R&D Officer | 67 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Joshua Resnick | 36 |
| Peter Kolchinsky | 32 |
| Peter Bisgaard | 28 |
| Risa Stack | 25 |
| Jason Lettmann | 21 |
| Andrew Levin | 21 |
| James M. Denny | 19 |
| David Lubner | 19 |
| Robert A. Heft | 18 |
| Reza Halse | 18 |
| Derek DiRocco | 17 |
| Raj Shah | 16 |
| Maria Fardis | 15 |
| James McArthur | 15 |
- Börse
- Insiders
- Ramin Farzaneh-Far
- Unternehmensverbindungen
